Project description
Novel testing methods for metabolism-disrupting chemicals
Metabolism-disrupting chemicals (MDCs) are natural and anthropogenic chemicals that disrupt the metabolism and ultimately result in obesity and diabetes. The EU-funded GOLIATH project aims to develop an integrated approach for testing and assessing MDCs. Researchers will focus on the main cellular targets of metabolic disruption and develop predictive models as well as toxicity screening assays. Combined with omics data, these tools will help decipher the endocrine mode of action and the adverse effects of MDCs on human health. The GOLIATH test methods have the potential to be exploited for regulatory use, leading to much anticipated guidelines.
Fields of science
Programme(s)
Topic(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
3584 CS Utrecht
Netherlands
See on map
Participants (15)
75007 Paris Cedex 07
See on map
LS2 7UE Leeds
See on map
75654 Paris
See on map
17177 Stockholm
See on map
03202 Elche
See on map
94700 Maisons Alfort
See on map
581 83 Linkoping
See on map
2400 Mol
See on map
UB8 3PH Uxbridge
See on map
Participation ended
CB2 1TN Cambridge
See on map
94607 Oakland Ca
See on map
35760 Saint Gregoire
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
33106 Paderborn
See on map
901 87 Umea
See on map
SW7 2AZ London
See on map